Empagliflozin in type 2 diabetes with and without CKD and non-diabetic CKD: Protocol for 3 randomized, double-blind, placebo controlled cross-over trials (Preprint)

Steffen Flindt Nielsen, Camilla Lundgreen Duus,Niels Henrik Buus,Jesper Nørgaard Bech,Frank Holden Mose

JMIR Research Protocols(2024)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要